On January 18, 2013, EJBrooks Company infringed its Patent Rights (US Patent No. 5851038) and claimed that some of the Instrument Sealing Rings and Components Thereof sold in the United States and sold in the US domestic market had infringed its patent rights. Investigate and issue general exclusion orders and prohibitions. The complainant suggested that Taiwan Mao Dah Enterprise be listed as a mandatory respondent in the case.
The United States “337 U.S. survey†prohibits all unfair competition or any unfair trade practices in exporting products to the United States. This unfair act specifically means that the product enters the United States with unfair competition or unfair behavior, or the owner, importer, or agent of the product sells the product in the U.S. market in an unfair manner, and U.S.-related industries cause substantial damage or damage, or impede the establishment of U.S. related industries, or suppress, manipulate U.S. businesses and trade, or infringe upon legitimate and effective U.S. trademarks and patents, or infringe the layout of integrated circuit chips. Rights, or infringement of other design rights protected by U.S. law, and the existence of related industries or related industries in the United States are being established.
At present, the US ITC is reviewing the application to decide whether to formally file the case.
Intravenous Injection Of Human Immunoglobulin
[Composition]
The main component of this preparation is human immunoglobulin, which is prepared by cold ethanol fractionation of human plasma from healthy donors. The manufacturing process contains a step to remove anticomplementary activity and a dual viral inactivation process. It contains a suitable amount of glucose or maltose as stabilizer (see table below), but does not contain any antiseptic or antibiotic. The distribution of IgG subclasses is close to the serum level of normal subjects and maintains the bioactivity of Fc fragment of IgG.
[Indications]
1. Primary
agammaglobulinemia, such as X-linked hypogammaglobulinemia,
common variant immunodeficiency diseases, immunoglobulin G subclass deficiency,
etc.
2. Secondary
immunoglobulin deficiency diseases, such as severe infection, septicemia of
newborn, etc
Intravenous Injection Of Human Immunoglobulin,Intravenous Immunoglobulin,High-Quality Effective Intravenous Immunoglobulin,Human Immunoglobulin For Intravenous Injection
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. , https://www.syimmunoglobulin.com